Minimally Invasive Surgery Treats Colorectal Cancer
Colorectal cancer ranks as the second leading cause of cancer-related deaths in the United States when combining both sexes, according to the American Cancer Society’s 2013 statistics.
With advanced treatments now available, colorectal cancer-related deaths can be significantly reduced. “If we can catch it in time, we can cure it,” says Ben Mizrahi, MD, a double-boarded colorectal surgeon at Colorectal Surgery Associates, PC. With the 2010 addition of his subspecialty of minimally invasive rectal surgery, Dr. Mizrahi became unique in the Northland.
Dr. Mizrahi says, “Approximately 98% of my surgeries are minimally invasive.” This includes removal of low-lying rectal lesions, avoiding a permanent colostomy, without rendering the patient incontinent.
Robotic/Laparoscopic Rectal Surgery
“Even with men, who have narrower pelvises, we get below the lesion using the robot,” he explains. “We can go as low in the pelvis as necessary and avoid the necessity for a permanent colostomy, so the patient can lead a more normal life.” Dr. Mizrahi says his mission is to, “do the best I can for each patient and cure the underlying disease process so they can have a faster recovery, and more quickly return to normal function.”
Advanced Treatments Available
“Using the advanced techniques now available allows for better oncologic outcomes,” Dr. Mizrahi explains. “I’m committed to minimally invasive surgery, which allows me to remove the cancer and increase patients’ long-term survival, with a quicker recovery and decreased need for narcotics.”
Dr. Mizrahi specializes in minimally invasive laparoscopic and robotic surgery. His specialty includes:
- Sphincter-saving procedures for rectal cancer which avoids the need for colostomies
- Incisionless transanal endoscopic microsurgery (TEM) to remove low-lying rectal lesions
- Treatment of complex anorectal disorders, including hemorrhoids, abscess and fistula
- Treatment of pelvic floor dysfunction, including constipation and incontinence
- Treatment of inflammatory bowel disease, including ulcerative colitis and Crohn disease
Approximately one in 12 American adults experience fecal incontinence, reports the National Digestive Disease Information Clearinghouse. Dr. Mizrahi has expertise in placing sacral nerve stimulators and injecting the sphincter muscles to help patients have better control.
Partnership Expands Options
With the recent partnership formed between North Kansas City Hospital and The University of Kansas Hospital, Northland patients now have increased access to treatments for complex cancers. Dr. Mizrahi’s cancer patients have the option of receiving all of their cancer treatment at North Kansas City Hospital.
Ben Mizrahi, MD
Dr. Mizrahi received his medical degree from the University of Vermont College of Medicine and completed his general surgery residency at the University of South Florida. Prior to his colorectal surgery fellowship at the Colorectal Clinic of Orlando, he completed an additional year of subspecialty training in minimally invasive colorectal surgery and advanced rectal care management at Marks Colorectal Clinic in Pennsylvania. He joined Colorectal Surgery Associates in 2010.
To learn more, call 816-941-0800.